Takeda stated it would continue to supply both medications to current patients until inventory is depleted or expires in mid-2026.  If you rely on one of these products, please reach out to your specialty pharmacy with any questions.  You should have received a letter in the mail also.  More information can be found at: https://www.bleeding.org/news/breaking-news-takeda-announces-discontinuation-of-two-hemophilia-treatments.